Targeting regulation of VEGF by BPTF in non-small cell lung cancer and its potential clinical significance
Abstract Purpose VEGF facilitates tumor angiogenesis, and bevacizumab targeting VEGF is used in anti-tumor therapy. It is meaningful to clarify the upstream regulatory mechanism of VEGF. BPTF is important in chromosomal remodeling, and promotes the progression of tumors. However, its role in promoti...
Main Authors: | Meng Dai, Chunyu Hua, Mingqin Wang, Li Gao, Ling Jiang, Yuan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-022-00935-1 |
Similar Items
-
BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target
by: Vladimir Bezrookove, et al.
Published: (2022-11-01) -
The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
by: Domenico Ribatti, et al.
Published: (2021-07-01) -
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
by: Raúl Muñoz Velasco, et al.
Published: (2022-03-01) -
PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer
by: Sheng Gao, et al.
Published: (2023-03-01) -
Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities
by: Aysegül Tura, et al.
Published: (2019-06-01)